HUMANIZED IL-25 ANTIBODIES
The present invention relates to target binding members (e.g., antibodies) that bind a specified epitope of human IL-25. The invention also relates to target binding members (e.g., antibodies) that comprise one or more humanized antibody VL domain sequences and bind IL-25. The invention further rela...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; hun |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | WHEELER, John TAUDTE, Susann ALMAGRO, Juan STROHL, William TORNETTA, Mark BRANIGAN, Patrick KANE, Colleen |
description | The present invention relates to target binding members (e.g., antibodies) that bind a specified epitope of human IL-25. The invention also relates to target binding members (e.g., antibodies) that comprise one or more humanized antibody VL domain sequences and bind IL-25. The invention further relates to compositions comprising target binding members (e.g., antibodies) that bind IL-25, methods of producing such target binding members, and uses of such target binding members for the treatment or prevention of diseases and conditions (e.g., asthma, inflammatory bowel disease). |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUE036157TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUE036157TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUE036157TT23</originalsourceid><addsrcrecordid>eNrjZJDyCPV19POMcnVR8PTRNTJVcPQL8XTyd_F0DeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEeoa4GxmaGpuYhIUbGxKgBACOLIJE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HUMANIZED IL-25 ANTIBODIES</title><source>esp@cenet</source><creator>WHEELER, John ; TAUDTE, Susann ; ALMAGRO, Juan ; STROHL, William ; TORNETTA, Mark ; BRANIGAN, Patrick ; KANE, Colleen</creator><creatorcontrib>WHEELER, John ; TAUDTE, Susann ; ALMAGRO, Juan ; STROHL, William ; TORNETTA, Mark ; BRANIGAN, Patrick ; KANE, Colleen</creatorcontrib><description>The present invention relates to target binding members (e.g., antibodies) that bind a specified epitope of human IL-25. The invention also relates to target binding members (e.g., antibodies) that comprise one or more humanized antibody VL domain sequences and bind IL-25. The invention further relates to compositions comprising target binding members (e.g., antibodies) that bind IL-25, methods of producing such target binding members, and uses of such target binding members for the treatment or prevention of diseases and conditions (e.g., asthma, inflammatory bowel disease).</description><language>eng ; hun</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180628&DB=EPODOC&CC=HU&NR=E036157T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180628&DB=EPODOC&CC=HU&NR=E036157T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WHEELER, John</creatorcontrib><creatorcontrib>TAUDTE, Susann</creatorcontrib><creatorcontrib>ALMAGRO, Juan</creatorcontrib><creatorcontrib>STROHL, William</creatorcontrib><creatorcontrib>TORNETTA, Mark</creatorcontrib><creatorcontrib>BRANIGAN, Patrick</creatorcontrib><creatorcontrib>KANE, Colleen</creatorcontrib><title>HUMANIZED IL-25 ANTIBODIES</title><description>The present invention relates to target binding members (e.g., antibodies) that bind a specified epitope of human IL-25. The invention also relates to target binding members (e.g., antibodies) that comprise one or more humanized antibody VL domain sequences and bind IL-25. The invention further relates to compositions comprising target binding members (e.g., antibodies) that bind IL-25, methods of producing such target binding members, and uses of such target binding members for the treatment or prevention of diseases and conditions (e.g., asthma, inflammatory bowel disease).</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDyCPV19POMcnVR8PTRNTJVcPQL8XTyd_F0DeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEeoa4GxmaGpuYhIUbGxKgBACOLIJE</recordid><startdate>20180628</startdate><enddate>20180628</enddate><creator>WHEELER, John</creator><creator>TAUDTE, Susann</creator><creator>ALMAGRO, Juan</creator><creator>STROHL, William</creator><creator>TORNETTA, Mark</creator><creator>BRANIGAN, Patrick</creator><creator>KANE, Colleen</creator><scope>EVB</scope></search><sort><creationdate>20180628</creationdate><title>HUMANIZED IL-25 ANTIBODIES</title><author>WHEELER, John ; TAUDTE, Susann ; ALMAGRO, Juan ; STROHL, William ; TORNETTA, Mark ; BRANIGAN, Patrick ; KANE, Colleen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUE036157TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>WHEELER, John</creatorcontrib><creatorcontrib>TAUDTE, Susann</creatorcontrib><creatorcontrib>ALMAGRO, Juan</creatorcontrib><creatorcontrib>STROHL, William</creatorcontrib><creatorcontrib>TORNETTA, Mark</creatorcontrib><creatorcontrib>BRANIGAN, Patrick</creatorcontrib><creatorcontrib>KANE, Colleen</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WHEELER, John</au><au>TAUDTE, Susann</au><au>ALMAGRO, Juan</au><au>STROHL, William</au><au>TORNETTA, Mark</au><au>BRANIGAN, Patrick</au><au>KANE, Colleen</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HUMANIZED IL-25 ANTIBODIES</title><date>2018-06-28</date><risdate>2018</risdate><abstract>The present invention relates to target binding members (e.g., antibodies) that bind a specified epitope of human IL-25. The invention also relates to target binding members (e.g., antibodies) that comprise one or more humanized antibody VL domain sequences and bind IL-25. The invention further relates to compositions comprising target binding members (e.g., antibodies) that bind IL-25, methods of producing such target binding members, and uses of such target binding members for the treatment or prevention of diseases and conditions (e.g., asthma, inflammatory bowel disease).</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; hun |
recordid | cdi_epo_espacenet_HUE036157TT2 |
source | esp@cenet |
subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
title | HUMANIZED IL-25 ANTIBODIES |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T18%3A33%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WHEELER,%20John&rft.date=2018-06-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUE036157TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |